ANKRD26
protein-codingankyrin repeat domain containing 26, the group of Ankyrin repeat domain containing
Gene summary
This gene encodes a protein containing N-terminal ankyrin repeats which function in protein-protein interactions. Mutations in this gene are associated with autosomal dominant thrombocytopenia-2. Pseudogenes of this gene are found on chromosome 7, 10, 13 and 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
- THC2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~126.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008555
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0008555
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008555
Submitter: ClinGen
ANKRD26 was first reported in relation to autosomal dominant thrombocytopenia 2 in 2011 (Pippucci T, et al., PMID: 21211618). At least 20 unique variants (in the 5’UTR) have been reported in humans. Evidence supporting this gene disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 18 probands in 7 publications (PMIDs: 26175287, 23677566, 30747248, 28109976, 24030261, 21467542, 21211618). Variants in this gene segregated with disease in 38 additional family members. The mechanism of disease is proposed to be gain of function, not haploinsufficiency (PMIDs: 21211618, 24430186). This gene-disease relationship is supported by altered expression and function in patient cells during megakaryopoeisis and proplatelet formation, as well as the rescue of proplatelet formation in patient cells by shRNA knockdown (PMID 24430186). In summary ANKRD26 is definitively associated with autosomal dominant thrombocytopenia 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0015679
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008555
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008555
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018874
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Individuals may have bleeding tendency, and awareness may allow precautions (eg, in surgical situations) and prompt treatment, which may be beneficial
Comments: A variant in ABCD5 was reported as causative
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ANKRD26 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014915.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 677 | 686 | |||
| missense | 1888 | 171 | 14 | 2073 | ||
| nonsense | 1 | 1 | 26 | 2 | 30 | |
| start loss | 2 | 2 | ||||
| frameshift | 1 | 54 | 1 | 56 | ||
| splice donor/acceptor (+/-2bp) | 23 | 23 | ||||
| Total | 1 | 2 | 2002 | 851 | 14 | 2870 |
Highest pathogenic variant AF is 0.000017968072
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055730.2 | 34 | MANE Select | |
| Ensembl | ENSP00000365255.4 | 34 | MANE Select | |
| RefSeq | NP_001242982.1 | 34 | Standard | |
| Ensembl | ENSP00000405112.3 | 34 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of fat cell differentiation
Molecular Function
- protein binding
Cellular Component
- centrosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000376087
- Coding exons
- 34
- Length
- 108579
- Individuals with no LoFs
- 124625
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 180
- Defined
- 124805
- p
- 0.000721
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.396 | 855 | 823 | 1.04 | 0.0000387 | 11402 |
| Missense (PolyPhen) | 147 | 160.19 | 0.91764 | 2511 | ||
| Synonymous | 0.161 | 291 | 295 | 0.988 | 0.0000145 | 2917 |
| Loss of Function | 3.68 | 53 | 90.9 | 0.583 | 0.00000428 | 1221 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00078 | 0.00078 | rare |
| Latino/Admixed American | 0.0010 | 0.0010 | notable |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00045 | 0.00044 | rare |
| Finnish | 0.0014 | 0.0014 | notable |
| European (Non-Finnish) | 0.00060 | 0.00060 | rare |
| South Asian | 0.00063 | 0.00062 | rare |
| Other | 0.0010 | 0.00099 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a regulator of adipogenesis. Involved in the regulation of the feeding behavior. {ECO:0000250|UniProtKB:Q811D2}.;
- Disease
- DISEASE: Thrombocytopenia 2 (THC2) [MIM:188000]: Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. {ECO:0000269|PubMed:21211618}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- LoFtool
- 0.985
- RVIS EVS
- 2.15
- RVIS percentile EVS
- 97.98
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.287
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |